| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |